LifeTech Scientific Corporation (LIFETECH SCI) reported no movements in either authorised or issued share capital during April 2026, according to its monthly return filed with Hong Kong Exchanges and Clearing Limited on 7 May 2026.

Authorised / Registered Share Capital • Authorised share capital held steady at USD 50,000, representing 40.00 billion ordinary shares with a par value of USD 0.00000125 each. • No increase or decrease was recorded during the month.

Issued Shares and Treasury Shares • Issued ordinary shares remained unchanged at 4.63 billion. • The company held zero treasury shares at both the beginning and end of the period. • Consequently, total issued share capital and shares in public hands were unchanged.

Public Float • LIFETECH SCI confirmed compliance with the Main Board’s minimum 25 % public-float requirement as at 30 April 2026.

Share-Based Incentive Schemes • Two share option schemes remained active: – Scheme 1: 25.41 million options outstanding, all exercisable; no options were exercised, cancelled or lapsed during the month. – Scheme 2 (approved 17 September 2021): 283.41 million options outstanding. Of these, 91.05 million could be issued as shares immediately, while 151.38 million additional shares could be issued upon future grants. • No new shares were issued and no funds were raised from option exercises in April 2026.

Other Securities • The company reported no warrants, convertible instruments, or other equity-linked securities outstanding or exercised during the month.

Summary LifeTech Scientific’s April 2026 filing indicates a stable capital structure, with no share issuance, buy-backs, or treasury-stock activity. Existing option pools remain sizeable, but none were exercised, leaving both cash position and share count unaffected for the month.